ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Rejection"

  • 2017 American Transplant Congress

    Novel Biomarkers for Segregating Lung Transplant Rejection Phenotypes.

    J. Yang,1 B. Vanaudenaerde,2 T. Sigdel,1 J. Liberto,1 S. Verlden,2 M. Sarwal.1

    1Department of Surgery, University of California, San Francisco, San Francisco, CA; 2Department of Pneumology, University of Leuven, Leuven, Flemish Brabant, Belgium

    We sought to investigate biomarkers in BAL fluid and tissue for segregating BOS and RAS chronic rejection phenotypes in lung allografts. We had previously identified…
  • 2017 American Transplant Congress

    Integrated Magnetic-Electrochemical Exosome (iMEX) Technology to Detect Rejection in Kidney Transplant Recipients.

    J. Assaker, J. Park, S. Routray, S. Eskandari, H. Lee, J. Azzi.

    Transplantation Research Center, Harvard Medical School, Boston; Exosome Diagnostic Inc, Cambridge

    Methods for monitoring clinical rejection including increases in serum creatinine and urinary protein excretion may not reflect subclinical rejection. Similarly repeat biopsy may result in…
  • 2017 American Transplant Congress

    Liver Transplantation Outcomes Using Anti-Thymocyte Globulin Induction in Patients with Autoimmune Hepatitis.

    S. LeCorchick, A. Sharma, I. Yakubu, C. Bhati, T. Reichman, L. Kang, M. Levy.

    Transplantation Surgery, Virginia Commonwealth University, Richmond, VA

    Background: The use of rabbit anti-thymocyte globulin (ATG) induction in high immunological risk patients with autoimmune hepatitis (AIH) could lower the rejection rates after liver…
  • 2017 American Transplant Congress

    Molecular Analysis of Acute Rejection in Formalin-Fixed Paraffin-Embedded Clinical Face Transplant Biopsies.

    T. Win,1 B. Dyring-Andersen,1 V. Barrera,2 S. Ho Sui,2 R. Lopdrup,1 H. Kiwanuka,1 N. Murakami,1 J. Teague,1 E. Lowry,1 E. Bueno,1 A. Chandraker,1 L. Riella,1 B. Pomahac,1 R. Clark.1

    1Brigham and Women's Hospital, Boston, MA; 2Harvard T.H. Chan School of Publich Health, Boston

    BackgroundDiagnosis of acute rejection in face transplants relies on the histological evaluation of allograft skin biopsies using BANFF classification, an approach with significant limitations including…
  • 2017 American Transplant Congress

    Gene Expression Profiling for the Identification and Classification of Antibody-Mediated Heart Rejection.

    A. Loupy,1 J. Duong Van-Huyen,1 L. Hidalgo,2 J. Reeve,2 M. Racapé,1 O. Aubert,1 J. Venner,2 D. Viglietti,1 P. Bruneval,1 C. Lefaucheur,1 P. Halloran.2

    1Paris Translational Research Center for Organ Transplantation, Paris, France; 2University of Alberta, Edmonton, Canada

    Antibody-mediated rejection (AMR) is a major determinant of heart allograft loss. However, the specific effects of anti-HLA antibodies on heart allograft injury have not been…
  • 2017 American Transplant Congress

    The Natural History of Kidney Rejection: How Do Molecular Disease States Change Over Time in Patients with Repeat Indication Biopsies?

    J. Reeve, P. Halloran.

    University of Alberta, Edmonton, AB, Canada

    Molecular phenotypes are highly reproducible, but how do they evolve over time? In an unsupervised microarray analysis, 1208 kidney transplant biopsies were assigned to one…
  • 2017 American Transplant Congress

    Early and Late Antibody Mediated Rejection and Mixed Acute Rejection Are Clinically Distinct and Demonstrate Biologic Differences in Immunodominant Donor Specific Antibody Characteristics.

    A. Lichvar,1 E. Portwood,1 P. Brailey,1 S. Tremblay,1 A. Shields,2 A. Govil,1 M. Cardi,2 M. Cuffy,1 R. Alloway,1 A. Girnita,1 E. Woodle.1

    1U of Cincinnati, Cincinnati; 2The Christ Hospital, Cincinnati

    Early and late antibody mediated rejection (AMR) and mixed acute rejection (MAR) possibly result from fundamentally different immunologic processes. DSA mediates direct injury by complement-dependent…
  • 2017 American Transplant Congress

    Early Antibody-Mediated Rejection C4d Status Remains a Marker of Prognosis in HLA-Incompatible Kidney Transplantation.

    J. Malheiro,1 S. Santos,1 S. Tafulo,2 L. Dias,1 L. Martins,1 J. Ramon,1 A. Castro-Henriques.1

    1CHP, Porto, Portugal; 2IPST, Porto, Portugal

    Banff criteria for the diagnosis of antibody-mediated rejection (AMR) in kidney transplantation (KT) was recently updated to include the entity of C4d negative AMR, if…
  • 2017 American Transplant Congress

    Human Transitional B Cell Cytokine Profile Predicts Renal Allograft Rejection and Clinical Course.

    A. Cherukuri, A. Sharma, R. Mehta, S. Hariharan, D. Rothstein.

    UPMC, Pittsburgh

    In Kidney Transplant Recipients (KTRs), non-invasive predictive biomarkers that allow early intervention are limited. Here we report findings from a prospective longitudinal study using B…
  • 2017 American Transplant Congress

    Apoptotic Exosome-Like Vesicles Released During Tissue Injury Trigger IL23/IL-17 Autoimmune Axis and Accelerate Rejection.

    M. Dieudé,1,4 J. Turgeon,1,4 A. Karakeussian-Rimbault,1,4 L. Pomerleau,1 A. Robitaille,1 N. Grandvaux,1 É. Boilard,2,4 M.-J. Hébert.1,3,4

    1Research Centre, Centre Hospitalier de l'Université de Montréal, Montreal, Canada; 2CHU de Québec, Québec, Canada; 3Montreal University, Montreal, QC, Canada; 4Canadian National Transplantation Research Program, Edmonton, Canada

    Autoantibodies to apoptotic antigens, such as perlecan/LG3, are present pre-transplantation and contribute to organ rejection. We previously showed that during tissue injury, apoptotic endothelial cells…
  • « Previous Page
  • 1
  • …
  • 111
  • 112
  • 113
  • 114
  • 115
  • …
  • 172
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences